Industry
Alembic Pharma Q2 net surges 81% to ₹335 crore
Aurobindo Pharma Q2 net up 32.5% to ₹1,124 cr on higher revenue
ED action in Reliance Anil Ambani Group cases | Explained
CERT-In calls for testing AI agents for unauthorised tool use, privilege abuse
India secures $400-bn investment commitments in renewables; ALMM review in 15 days
M&M Q2 PAT rises 25% to ₹4,588 crore on strong auto, finance performance
The Hindu - Industry·5 Nov 2026
Auto continued to grow on the back of strong consumer demand, while Farm experienced a marginal decline on account of the festive season shift.
More news in Industry
Alembic Pharma Q2 net surges 81% to ₹335 croreAurobindo Pharma Q2 net up 32.5% to ₹1,124 cr on higher revenueED action in Reliance Anil Ambani Group cases | ExplainedCERT-In calls for testing AI agents for unauthorised tool use, privilege abuseIndia secures $400-bn investment commitments in renewables; ALMM review in 15 days